Authors
Latest:
Navigating Patient Treatment in Oncology to Fill Gaps in CareOncology pharmacists can help ensure patient access to lifesaving therapies.
Latest:
Toxicology: Is It Influenced by Pharmacogenetics?Numerous, important differences exist in the ways that humans metabolize xenobiotics. These interindividual differences can directly affect the efficacy and toxicity of drugs and other foreign substances.
Latest:
Prepare the Pharmacy for the Next CrisisA well-drafted business continuity plan enables continued operations, mitigates potential risks.
Latest:
Women in Pharmacy Should Band Together to Overcome ObstaclesNetworking and being prepared and educated are keys to succeeding as women in the pharmacy field.
Latest:
Does Your Controlled Substance Compliance Program Adequately Address Pharmacists’ Corresponding Responsibility?Pharmacists struggling to reconcile their duty to dispense with legal obligations to prevent drug diversion must exercise judgment when determining whether a prescription is suspect or legitimate.Â
Latest:
HIV PrEP: An Opportunity for PharmacistsWhen taken daily, PrEP is highly effective for preventing HIV from sex or injection drug use.
Latest:
New ACT Program Brings Challenges and BarriersBoise VA Medical Center in Idaho develops an accuracy checking technician service and shares lessons from the implementation.
Latest:
Joan Rivers' Death Highlights Risks of Surgical ComplicationsPerioperative cardiac arrest due to anesthetics does not occur frequently, but still represents a serious surgical risk.
Latest:
Self-Reported Plan Switching in Medicare Part D: 2006-2010Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.
Latest:
Mission Trip to Fort Liberte, HaitiA pharmacist's services prove to be invaluable on a medical mission trip to Fort Liberte, Haiti.
Latest:
Value-Based Design and Prescription Drug Utilization Patterns Among Diabetes PatientsChanges in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.
Latest:
FDA Approves Component of Cancer Treatment Regimen for Patients With ALL, LBLAsparaginase erwinia chrysanthemi (recombinant)-rywn) (Rylaze; Jazz Pharmaceuticals) provides a new alternative for a therapy in long-standing global shortage.
Latest:
EntrestoEntresto is a combination of a first-in-class neprilysin inhibitor and an angiotensin receptor blocker indicated for the treatment of heart failure with reduced ejection fraction.
Latest:
Use Asembia to Take Stock Before Going to MarketAsembia is great not only for networking conversations that can lead to transactions but also for taking stock of your organization.
Latest:
The Pharmacy Benefit vs the Medical BenefitComprehensive pharmacy services would mean having the pharmacy team develop the management strategy for specialty medications used under either the medical benefit or the pharmacy benefit.
Latest:
Examining Recent Advances in Understanding and Treatment of Dry Eye Disease: An Eye on the Pharmacist's RoleThis Continuing Education activity is supported by an educational grant from Alcon, Inc.
Latest:
Changes Afoot for 2017 Marketplace Insurance PlansLooking forward to the Affordable Care Act in 2017, the patient community analyzes a list of improvements that HHS has proposed for the insurance marketplace.
Latest:
Patient Engagement and Wellness: A Critical Piece of the Puzzle as Health Care Moves to Value-Based ModelsAlthough we have seen some progress through the proliferation of patient-centered medical homes, most clinicians have not fundamentally altered their basic approach to engaging with their patients.
Latest:
Responding Proactively to Antikickback GuidelinesThe time has come to be proactive in finding a path that can benefit all potential stakeholders, rather than letting other third parties define the system in a way that negatively affects potential outcomes.
Latest:
New Law Brings Changes to Medicare Part DAn overview of the landmark Medicare Part D program 3 years since its inception, with guidance for pharmacists on how new provisions in the 2008 Medicare Act will affect their practice.
Latest:
New Prescribing Options in Metastatic MelanomaThis review presents data on ipilimumab and vemurafenib, 2 new targeted agents recently approved for the treatment of metastatic melanoma.
